SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.08-2.9%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (23480)4/18/2007 1:00:20 AM
From: John Metcalf  Read Replies (1) of 52153
 
"frodo's approval for menstrual pain"

Geeze, where to start? So glad you are relieved of menstrual pain. I realize the pain was not your own. I've been married 32 years. That's long enough for me to be relieved of the vicious second-hand results of menstrual pain, which are not sufficiently understood by FDA.

We've been going back and forth for years over the argument as to whether FDA leans towards safety, or towards efficacy. Do they wrong more people by saving them from harm or wrong more people by preventing them from cure?

Until Dubya issues a contrary signing statement, with approval from Alberto Gonzales, FDA is required to rule, "yes" or "no", whether a drug is safe and efficacious. To me, that means that comparisons to other drugs is not a legitimate part of an FDA ruling. If you hit the marks of competitors, you should be approved, and after that, let God sort it out. (Just pandering to Dubya, I think the consumer should sort it out.) What am I missing, besides political awareness?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext